TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Medibank Private ( (AU:MPL) ) is now available.
Medibank Private Limited has announced a change in the director’s interest, specifically regarding Jay Weatherill, who has acquired an additional 5,900 ordinary shares, bringing his total to 22,600 shares. This change reflects an increased personal investment in the company, potentially signaling confidence in Medibank’s future performance and stability, which may influence investor perception and market dynamics.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.05 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a prominent player in the health insurance industry, providing a range of health insurance products and services. The company is focused on delivering quality healthcare solutions and maintaining a strong market presence in Australia.
Average Trading Volume: 5,457,200
Technical Sentiment Signal: Buy
Current Market Cap: A$14.05B
Find detailed analytics on MPL stock on TipRanks’ Stock Analysis page.